NYSE : NUS
-$0.32 (-5.83%)
| Source | Headline |
|---|---|
|
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-08-11 06:58:23 |
|
Nu Skin Enterprises Q2 Earnings Call Highlights
Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives. marketbeat.com - 2026-08-11 00:04:10 |
|
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.2 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.43 per share a year ago. zacks.com - 2026-08-10 18:21:08 |
|
Nu Skin Enterprises Reports Second Quarter Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results. Executive Summary Q2 2026 vs. Prior-year Quarter Revenue $320.1 million; (17.1)% (1.0)% FX impact or $(4.0) million Earnings Per Share (EPS) $(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43 Customers 660,037; (14)% Paid Affiliates 120,291; (8)% Sales Leaders 26,998; (9)% “We continue to make progress toward our long-term strategy with the continued. businesswire.com - 2026-08-10 16:06:00 |
|
Nu Skin Enterprises Announces Quarterly Dividend
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on Sept. 9, 2026, to shareholders of record on Aug. 28, 2026. About Nu Skin Enterprises Inc. Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scien. businesswire.com - 2026-08-10 16:05:00 |
|
Head-To-Head Analysis: BioHarvest Sciences (NASDAQ:BHST) versus Nu Skin Enterprises (NYSE:NUS)
Nu Skin Enterprises (NYSE: NUS - Get Free Report) and BioHarvest Sciences (NASDAQ: BHST - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Volatility and Risk Nu Skin defenseworld.net - 2026-08-04 01:59:07 |
|
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2026 results after the market closes on Monday, Aug. 10. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor. businesswire.com - 2026-07-21 16:18:00 |
|
July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys
July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks meeting this ideal condition. seekingalpha.com - 2026-07-11 06:01:57 |
|
20 July Ideal 'Safer' Russell Index Buys You Might Choose To Hold Forever
Russell 2000 & 3000 Maybe Hold Forever Stocks (MHFS) featured high (>4%) dividends, attractive or neutral ratings, >2-year dividend history, and positive cash flow per YCharts stock screener. The resulting list targets investors who “want to simply focus on profitable stocks without the fuss and bother of anything but an annual review and rebalance." 38 MHFS, from the Russell 2000/3000 2026 batch screened as of 7/6/26 represented all eleven Morningstar sectors. Broker estimated top-ten net gains ranged from 29.47% to 89.14%. seekingalpha.com - 2026-07-09 14:42:36 |
|
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics to highlight potential upside opportunities. zacks.com - 2026-06-30 09:55:40 |
|
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited recession resistance and weak operating cash flow. The India market expansion is a key strategic focus, but execution risks are high and infrastructure investments will elevate fixed costs. NUS's working capital intensity pose cash flow risks even in growth, despite low net debt and recent refinancing extending maturities to 2031. seekingalpha.com - 2026-06-30 09:55:30 |
|
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026. zacks.com - 2026-06-30 09:40:25 |
|
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com - 2026-06-29 11:16:14 |
|
4 Cosmetics Stocks Worth Watching on Favorable Industry Trends
EL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding digital channels. zacks.com - 2026-06-17 12:01:05 |
|
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backed by valuation and debt filters. zacks.com - 2026-06-16 10:51:28 |
|
13 Lucky Dogs: June Graham Value All-Stars (GVAS)
The June GVAS portfolio highlights 13 'safer,' fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins. Top ten GVAS stocks are forecasted to deliver average net gains of 39.68% by June 2027, with yields ranging from 7.9% to 16.46%. Energy and financial sectors dominate the highest-yielding, lowest-priced GVAS, with Okeanis Eco Tankers and IRSA Inversiones offering standout upside potential. seekingalpha.com - 2026-06-04 07:49:26 |
|
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with balance-sheet and value checks for upside. zacks.com - 2026-06-02 10:01:32 |
|
5 Value Stocks Trading at Attractive Price-to-Sales Ratios
Low price-to-sales stocks like SCVL, NUS, APLE, COP and FAF screen as undervalued, with the setup hinging on debt levels, strong cash flow and business momentum. zacks.com - 2026-05-21 10:46:18 |
|
3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends
EL, NUS and COTY tap AI, wellness and innovation trends as beauty demand evolves across skincare, cosmetics and fragrance categories. zacks.com - 2026-05-20 09:56:02 |
|
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and wellness, today announced it has reached the milestone of providing 900 million meals for children since 2002 through its Nourish the Children initiative. Malnourished children in more than 65 countries around the world have been fed VitaMeal,* a nutrient-dense food, from one of the company's third-party charity partners after Nu Skin sales leaders, customers or employees purchase and donate bags. businesswire.com - 2026-05-15 07:00:00 |
|
Nu Skin Enterprises Q1 Earnings Call Highlights
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line with expectations, as the company continued to invest in its Prysm iO wellness platform and emerging-market expansion while navigating macroeconomic pressures on consumers and supply chains. marketbeat.com - 2026-05-13 04:09:53 |